Quantcast

Latest Cancer stem cell Stories

2014-04-18 15:49:22

Studies carry implications for understanding cancer Johns Hopkins researchers have discovered an unexpected phenomenon in the organs that produce sperm in fruit flies: When a certain kind of stem cell is killed off experimentally, another group of non-stem cells can come out of retirement to replace them. The discovery sheds light on the tiny "environments" that stem cells occupy in animal bodies and may help explain how stem cells in tumors replenish themselves, the researchers report...

2014-04-16 12:30:22

Advanced Tumor Modeling for Evaluation of Cancer Therapy Efficacy at the Cellular Level MENLO PARK, Calif., April 16, 2014 /PRNewswire/ -- SRI International has announced the availability of its PDCellX(TM) xenograft tumor model services for testing the activity of potential cancer therapeutics. PDCellX models provide clinically relevant information that allows researchers to evaluate the efficacy of cancer drug candidates in new models that go beyond traditional tumor xenograft...

2014-04-11 12:07:26

A group of researchers in China and the US have successfully created a 3D model of a cancerous tumor using a 3D printer. The model, which consists of a scaffold of fibrous proteins coated in cervical cancer cells, has provided a realistic 3D representation of a tumor's environment and could help in the discovery of new drugs and cast new light on how tumors develop, grow and spread throughout the body. The results of the study have been published today, 11 April, in IOP Publishing's...

2014-03-26 20:21:47

DUBLIN, March 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/7rc6qw/cancer_stem_cell) has announced the addition of the "Concise Analysis of the International Cancer Stem Cell Trends" [http://www.researchandmarkets.com/research/7rc6qw/cancer_stem_cell ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The report illustrates on the growing market for Cancer Stem Cells (CSCs) in the US...

2014-03-25 23:28:12

GIA announces the release of a comprehensive global report on Circulating Tumor Cells and Cancer Stem Cells Technologies markets. Global market for Circulating Tumor Cells (CTC) Diagnostics is forecast to reach US$10 billion by 2020, driven by rising incidence of cancer, growing demand for effective diagnosis & treatment, and breakthrough research developments in understanding disease pathways. San Jose, California (PRWEB) March 25, 2014 Follow us on LinkedIn – High prevalence of...

2014-03-18 08:32:17

Experimental drug designed to fight abdominal cancers passes important test SYDNEY, March 18, 2014 /PRNewswire/ -- Novogen Limited [ASX:NRT; NASDAQ:NVGN] and its joint venture company with Yale University, CanTx Inc, today announced an important milestone with lead candidate drug, Trx-1, demonstrating a potent anti-cancer effect in mice xenografted with human ovarian cancer stem cells. http://photos.prnewswire.com/prnvar/20131220/NY36990LOGO CanTx is seeking a novel approach to...

2014-03-10 08:30:35

BERGEN, Norway, March 10, 2014 /PRNewswire/ -- NOK 13 million funding secured from the Research Council of Norway BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, is pleased to announce the award of a NOK 13 million grant from the Research Council of Norway's User-driven Research based Innovation programme (BIA) to help fund research into novel therapeutics for inhibiting tumor epithelial-mesenchymal transition (EMT), a key...

Door To Undiscovered World Of Biology Opened By Stem Cell Study
2014-03-10 08:19:39

UT Southwestern Medical Center For the first time, researchers have shown that an essential biological process known as protein synthesis can be studied in adult stem cells – something scientists have long struggled to accomplish. The groundbreaking findings from the Children's Medical Center Research Institute at UT Southwestern (CRI) also demonstrate that the precise amount of protein produced by blood-forming stem cells is crucial to their function. The discovery, published online...

2014-02-13 10:35:34

Cancer researchers led by stem cell scientist Dr. John Dick have discovered a pre-leukemic stem cell that may be the first step in initiating disease and also the culprit that evades therapy and triggers relapse in patients with acute myeloid leukemia (AML). The research, published online today in Nature is a significant leap in understanding the steps that a normal cell has to go through as it turns into AML, says Dr. Dick, and sets the stage to advance personalized cancer medicine by...

2014-02-11 08:33:10

CAMBRIDGE, Mass., Feb. 11, 2014 /PRNewswire/ -- Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in an open label single-arm Phase 2 clinical trial of its lead candidate, CRLX101, in combination with Avastin (bevacizumab) in patients with relapsed ovarian cancer. The Phase 2 combination therapy trial of this investigational treatment is being conducted at Massachusetts General Hospital (MGH) and...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related